Ophiomics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

Ophiomics General Information

Description

Developer of a medical diagnostic product designed to integrate bioinformatics and genomics to detect liver cancer at an early stage. The company's products include biomarker-based diagnostic devices to identify hepatocellular carcinoma by integrating molecular signatures with clinical parameters in a predictive algorithm, enabling healthcare providers to detect lung cancer and improve prognosis in patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Pólo Tecnológico de Lisboa
  • Rua António Champalimaud, Lote 1 (sala 14)
  • Lisbon, 1600-513
  • Portugal
+351 21
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Pólo Tecnológico de Lisboa
  • Rua António Champalimaud, Lote 1 (sala 14)
  • Lisbon, 1600-513
  • Portugal
+351 21

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ophiomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 14-Dec-2025 Completed Generating Revenue
6. Secondary Transaction - Private Completed Generating Revenue
5. Later Stage VC (Series A) 08-Dec-2022 Completed Generating Revenue
4. Later Stage VC 28-Apr-2021 Completed Generating Revenue
3. Grant 28-Sep-2020 Completed Generating Revenue
2. Grant 09-Oct-2019 $833K Completed Generating Revenue
1. University Spin-Out 01-Jan-2015 Completed Startup
To view Ophiomics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Ophiomics Patents

Ophiomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4341441-A1 Dna methylation biomarkers for hepatocellular carcinoma Pending 21-May-2021
US-20240229158-A1 Dna methylation biomarkers for hepatocellular carcinoma Pending 21-May-2021
WO-2022243566-A1 Dna methylation biomarkers for hepatocellular carcinoma Inactive 21-May-2021 C12Q1/6886

Ophiomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ophiomics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Saudi Biotechnology Accelerator Accelerator/Incubator
BlueCrow Capital Venture Capital Minority
Everis Awards Not-For-Profit Venture Capital
Universidade NOVA de Lisboa University
To view Ophiomics’s complete investors history, request access »

Ophiomics FAQs

  • When was Ophiomics founded?

    Ophiomics was founded in 2015.

  • Where is Ophiomics headquartered?

    Ophiomics is headquartered in Lisbon, Portugal.

  • What is the size of Ophiomics?

    Ophiomics has 14 total employees.

  • What industry is Ophiomics in?

    Ophiomics’s primary industry is Diagnostic Equipment.

  • Is Ophiomics a private or public company?

    Ophiomics is a Private company.

  • What is Ophiomics’s current revenue?

    The current revenue for Ophiomics is .

  • How much funding has Ophiomics raised over time?

    Ophiomics has raised $1.19M.

  • Who are Ophiomics’s investors?

    Saudi Biotechnology Accelerator, BlueCrow Capital, Everis Awards, and Universidade NOVA de Lisboa have invested in Ophiomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process